Bavarian Nordic AS (CHIX:BAVAC) FFO


CHIX:BAVAC Bavarian Nordic AS CHIX:BAVAC
84 GF Score
Price kr188.30
GF Value kr175.27
Valuation Fairly Valued
! 2 Warning Signs
View Full Analysis

What is Bavarian Nordic AS FFO?

FFO (Funds from operations) only applies to REITs.

CHIX:BAVAC
84GF Score
Bavarian Nordic AS CHIX:BAVAC
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Bavarian Nordic AS (CHIX:BAVAC) Overvalued in 2026?

Based on GuruFocus' analysis, Bavarian Nordic AS stock appears to be overvalued. The current stock price of kr188.30 is trading 7.4% above its estimated GF Value™ of kr175.27. GuruFocus considers Bavarian Nordic AS to be Fairly Valued.

Key valuation signals for CHIX:BAVAC:

  • FFO:
  • GF Value™: kr175.27 vs. price of kr188.30 (7.4% above fair value)
  • GF Score™: 84/100 with 2 warning signs

No single metric tells the full story. See the CHIX:BAVAC stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Bavarian Nordic AS Business Description

Address Philip Heymans Alle 3, Hellerup, DNK, 2900
Bavarian Nordic AS is a biotechnology company focused on the research, development, manufacturing, and commercialization of life-saving vaccines. The group is a supplier of mpox and smallpox vaccines to governments to enhance public health preparedness and has a portfolio of travel vaccines. The vast majority of the company's revenue is generated in the United States, Germany, and other geographic markets. Its products include Encepur, Jynneos, Rabipur, Vaxchora, VIMKUNYA and Vivotif.
84GF Score

Get the complete analysis for CHIX:BAVAC

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

kr188.30
Price
kr175.27
GF Value